SYT11 Gene

SYT11 - Synaptotagmin 11

Introduction

Syt11 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<table class="infobox infobox-protein"> [@mcgough2020]
<tr> [@abeliovich2019]
<th class="infobox-header" colspan="2">SYT11 (Synaptotagmin 11)</th> [@karabogdan2017]
</tr> [@thirstrup2020]
<tr> [@lynchday2012]
<td class="infobox-header" colspan="2">Synaptic Vesicle Trafficking Protein</td> [@nixon2020]
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SYT11</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Synaptotagmin-11</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[SYT11](/genes/syt11)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/Q9BT88" target="_blank">Q9BT88</a></td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q41</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>47 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Synaptotagmin family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (high), particularly striatum and cortex</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

...

SYT11 - Synaptotagmin 11

Introduction

Syt11 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<table class="infobox infobox-protein"> [@mcgough2020]
<tr> [@abeliovich2019]
<th class="infobox-header" colspan="2">SYT11 (Synaptotagmin 11)</th> [@karabogdan2017]
</tr> [@thirstrup2020]
<tr> [@lynchday2012]
<td class="infobox-header" colspan="2">Synaptic Vesicle Trafficking Protein</td> [@nixon2020]
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SYT11</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Synaptotagmin-11</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[SYT11](/genes/syt11)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/Q9BT88" target="_blank">Q9BT88</a></td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q41</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>47 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Synaptotagmin family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (high), particularly striatum and cortex</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

SYT11 (Synaptotagmin 11) is a member of the synaptotagmin protein family that plays critical roles in synaptic vesicle trafficking and autophagy regulation. Located on chromosome 1q41, SYT11 has emerged as an important susceptibility gene for Parkinson's disease. Unlike other synaptotagmins, SYT11 lacks the calcium-binding C2 domains typically required for synaptic vesicle exocytosis, suggesting it functions primarily as a regulator of intracellular trafficking pathways rather than as a calcium sensor for neurotransmitter release @Burre2018.

The discovery of SYT11's association with PD emerged from genetic studies identifying rare coding variants that increase disease risk. Notably, reduced expression of SYT11 protein has been observed in post-mortem brain tissue from PD patients, particularly in the substantia nigra—the region most vulnerable to dopaminergic neuron loss. This suggests that SYT11 dysfunction may contribute to the selective vulnerability of these [neurons](/entities/neurons) through impaired synaptic maintenance and autophagy @Burre2018.

Molecular Function

Structure

SYT11 contains several key domains:

N-terminal transmembrane region (residues 1-60): Membrane anchor

Linker region (residues 61-150): Flexible cytoplasmic domain

C2 domains (inactive) (residues 151-350): Lacks calcium-binding capability

C-terminal region (residues 350-420): Regulatory functions

The absence of functional calcium-binding domains distinguishes SYT11 from canonical synaptotagmins like SYT1, which mediate fast synaptic transmission.

Interaction Partners

SYT11 interacts with several key proteins:

| Partner | Interaction | Functional Role |
|---------|-------------|-----------------|
| PI3K (Vps34) | Direct binding | [Autophagy](/entities/autophagy) initiation |
| Rab proteins | Unknown | Vesicle trafficking |
| SNARE complexes | Modulatory | Synaptic function |
| GGA proteins | Binding | Clathrin-mediated trafficking |

Role in Synaptic Function

Synaptic Vesicle Trafficking

Despite lacking calcium-binding ability, SYT11 participates in synaptic vesicle dynamics:

• Vesicle pool maintenance: Regulates the size and composition of synaptic vesicle pools
• Endocytosis: Modulates clathrin-mediated endocytosis at presynaptic terminals
• Synaptic homeostasis: Contributes to homeostatic plasticity mechanisms

Autophagy Regulation

SYT11's most well-characterized function is its role in autophagy:

PI3K/Vps34 Interaction:

• SYT11 directly interacts with class III PI3K (Vps34)
• This complex regulates the initiation of autophagosome formation
• Autophagy is critical for clearing damaged organelles and protein aggregates

PD Relevance:

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregates must be cleared via autophagy
• Impaired autophagy leads to toxic protein accumulation
• SYT11 dysfunction may contribute to this pathological process

Parkinson's Disease Pathogenesis

Genetic Evidence

SYT11 variants are associated with PD risk:

• Rare coding variants: Increase PD susceptibility
• Expression quantitative trait loci (eQTLs): Lower SYT11 expression linked to PD risk
• Genome-wide association studies: Consistent association signals near SYT11 locus

Expression Changes in PD

Reduced SYT11 in PD Brain:

• Substantia nigra shows marked decrease in SYT11 protein
• Striatal regions also exhibit reduced expression
• Correlates with dopaminergic neuron loss

Mechanistic Implications:

• Synaptic dysfunction precedes overt neurodegeneration
• Autophagy impairment contributes to [alpha-synuclein](/mechanisms/alpha-synuclein) accumulation
• May represent a therapeutic target

Link to Alpha-Synuclein

SYT11 and alpha-synuclein are both involved in synaptic function:

• Both regulate synaptic vesicle pools
• Autophagy clears excess alpha-synuclein
• SYT11 dysfunction may indirectly promote alpha-synuclein aggregation

Autophagy-Lysosomal Pathway

The Autophagy Pathway

SYT11 plays a role in regulating macroautophagy:

Initiation: PI3K/Vps34 complex forms omegasomes

Nucleation: LC3 lipidation and phagophore formation

Elongation: Autophagosome expands to engulf cargo

Fusion: Autophagosome fuses with lysosome

Degradation: Cargo is broken down and recycled

Lysosomal Dysfunction

In PD, lysosomal function is impaired:

• GCase mutations (GBA) cause glucocerebrosidase deficiency
• Lysosomal impairment reduces autophagic clearance
• SYT11 dysfunction compounds this deficit

Therapeutic Implications

Drug Development

| Approach | Target | Status |
|----------|--------|--------|
| Autophagy enhancers | [mTOR](/entities/mtor)-independent | Preclinical |
| Gene therapy | SYT11 expression | Experimental |
| Small molecules | Vps34 modulators | Screening |

Biomarker Potential

SYT11 expression:

• Blood: Peripheral marker of synaptic dysfunction
• CSF: Potential biomarker under investigation
• iPSC neurons: Patient-specific response to therapeutics

Other Neurological Disorders

Amyotrophic Lateral Sclerosis (ALS)

SYT11 may play a role in ALS:

• Motor neurons exhibit synaptic dysfunction
• Autophagy impairment is a common feature
• Genetic variants may modify disease progression

Alzheimer's Disease

In AD, synaptic loss is a hallmark:

• SYT11 expression changes in AD brain
• Autophagy is impaired by amyloid and [tau](/proteins/tau) pathology
• Potential therapeutic target

Schizophrenia

• SYT11 expression altered in prefrontal [cortex](/brain-regions/cortex)
• May contribute to synaptic dysfunction
• Further investigation needed

Research Methods

Experimental Approaches

Molecular biology: CRISPR/Cas9 gene editing

Biochemistry: Co-immunoprecipitation, Western blot

Live-cell imaging: Autophagy flux assays

Electrophysiology: Synaptic transmission studies

iPSC models: Patient-derived neurons

Animal Models

• Syt11 knockout mice: Viable but show synaptic alterations
• Parkinsonian models: MPTP, 6-OHDA treatment
• Transgenic models: Alpha-synuclein overexpression

Gene Information

• NCBI Gene ID: 23475
• OMIM: 608012
• Ensembl ID: ENSG00000137336
• Chromosome: 1
• Location: 1q41 (232,500,000-232,650,000)
• Exons: 14

Background

The study of Syt11 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• SYT11 Gene
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein Pathway](/proteins/alpha-synuclein)
• [Autophagy Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
• [Proteins Index](/proteins)
• [Genes Index](/genes)

Pathway Diagram

The following diagram shows the key molecular relationships involving SYT11 Gene discovered through SciDEX knowledge graph analysis: